1. Home
  2. NOTV vs XAIR Comparison

NOTV vs XAIR Comparison

Compare NOTV & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.30

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$1.04

Market Cap

11.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
XAIR
Founded
1974
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
11.4M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NOTV
XAIR
Price
$0.30
$1.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$1.50
$11.00
AVG Volume (30 Days)
408.1K
939.6K
Earning Date
02-09-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$514,027,000.00
$6,924,000.00
Revenue This Year
$6.49
$127.85
Revenue Next Year
$4.95
$179.78
P/E Ratio
N/A
N/A
Revenue Growth
8.19
129.04
52 Week Low
$0.28
$0.67
52 Week High
$4.51
$8.01

Technical Indicators

Market Signals
Indicator
NOTV
XAIR
Relative Strength Index (RSI) 23.09 42.33
Support Level $0.28 $0.95
Resistance Level $0.50 $1.15
Average True Range (ATR) 0.05 0.11
MACD -0.01 -0.03
Stochastic Oscillator 6.44 17.50

Price Performance

Historical Comparison
NOTV
XAIR

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: